Urologix

What Urologix does

Urologix, founded in 1991 and headquartered in Plymouth, Minnesota, is a medical device company that develops, manufactures, and sells minimally invasive, in-office systems for the treatment of benign prostatic hyperplasia (BPH). The company operates two core technology platforms: Cooled ThermoTherapy™ (CTT), a transurethral microwave thermotherapy (TUMT) system that delivers targeted microwave energy through a catheter while circulating cooling fluid to protect urethral tissue and maintain urethral temperatures at or below 40°C while reaching intraprostatic temperatures near 80°C; and Prostiva® RF Therapy, a transurethral needle ablation (TUNA) system that uses low-level radio frequency energy delivered through needle electrodes to coagulate enlarged prostate tissue at intraprostatic temperatures of approximately 110°C. Supporting components include the CoolWave and Targis control units, the CTC Advance catheter family in three lengths, the Rectal Thermal Sensing Unit with five thermosensors, and for Prostiva, an RF generator with touch-screen controls, a single-use hand piece, and reusable telescopes available in 0° and 15° angles. The Prostiva generator monitors urethral and prostatic temperatures six times per second, controls RF power 5,000 times per second, and measures impedance and power 50 million times per second, with 15 computer-monitored safety checks.

The company's commercial model is built around direct, US-only sales to urologists and urology practices through a field sales force supported by a customer service organization and a website-based physician locator. Revenue is generated primarily from hardware sales of control units and from recurring single-use procedure kits, catheters, and treatment components consumed during each in-office BPH procedure. Both treatments are performed in-office in under an hour without general anesthesia, are covered by Medicare across all 50 states and by most private insurers, and are positioned against long-term BPH medications and surgical interventions. Urologix markets to both patients (via educational content, seminars, testimonials, and media appearances) and clinicians (via a clinician resource library, the 'Urologic Highlights in Men's Health' newsletter, and clinical publications), and also operates a Mobile Services channel that brings equipment into practices that lack in-house capital.

Clinically, Urologix reports that Cooled ThermoTherapy has been used to treat over 225,000 men and Prostiva RF Therapy over 100,000 patients worldwide, supported by nearly 200 peer-reviewed clinical articles and presentations since 1991 across more than 50 centers. The company cites durable outcomes of over 90% reintervention-free at five years for CTT and over 86% for Prostiva, with symptom improvement typically reported within 6-12 weeks. The patient target population is men with moderate to severe lower urinary tract symptoms caused by BPH, and the immediate customer is the practicing urologist performing the in-office procedure.

Name

Urologix

Legal name

Urologix, LLC

Website

https://urologix.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

251–500 employees

Short description

Urologix is a Minnesota-based medical device company that manufactures and sells in-office BPH treatment systems — Cooled ThermoTherapy (microwave) and Prostiva RF Therapy — directly to US urologists and their practices.

Ownership category

akta.pro rank

Product category

Urology Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Endourology & Minimally Invasive Urologic Surgery (HLAKAOAF)

akta.pro secondary industries

General Urology (HLAKAOAA), Nephrology & Urology Specialty Pharmaceuticals (HLAIACAH)

Keywords

• Benign prostatic hyperplasia treatment
• Urology medical devices
• Minimally invasive BPH therapy
• Microwave thermotherapy systems
• Transurethral needle ablation

Headquarters

HQ city

Minneapolis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Medical Device Sales: Urologix generates revenue through the sale of its Cooled ThermoTherapy and Prostiva RF Therapy medical device systems, including control units, catheters, and related consumables to urologists and healthcare providers.
2. Procedure Kits and Consumables: Sale of single-use procedure kits, catheters, and treatment components that are consumed during BPH procedures performed in urologists' offices.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Urologix manufactures and distributes minimally invasive medical device systems for the in-office treatment of benign prostatic hyperplasia (BPH). The company sells two primary therapy platforms — Cooled ThermoTherapy (CTT), which uses transurethral microwave energy with proprietary urethral cooling, and Prostiva RF Therapy, which uses low-level radio frequency energy delivered via needle electrodes — along with the associated control units, catheters, and consumable procedure kits sold to urologists and urology practices.

Product overview

Urologix offers a portfolio of medical devices for in-office treatment of Benign Prostatic Hyperplasia (BPH). The company's core products are Cooled ThermoTherapy™ (CTT) using microwave technology and Prostiva® RF Therapy using radio frequency energy. Both are minimally invasive, non-surgical procedures performed in a urologist's office in under an hour without general anesthesia. The Cooled ThermoTherapy system includes the CoolWave or Targis Control Units, CTC Advance Microwave Catheters (in Short, Standard, and Long sizes), Rectal Thermal Sensing Unit, and Coolant Bag. The Prostiva RF system includes a Generator, Hand Piece, and Telescope. These products provide long-term relief from BPH symptoms with clinically proven durability lasting up to 5 years.

Differentiator

Problem solved

Functional benefit

Brands

• Cooled ThermoTherapy™: A safe, effective, in-office BPH treatment that provides long-term relief from BPH symptoms using microwave energy with advanced urethral cooling system.
• Prostiva® RF Therapy

Products and services

• Cooled ThermoTherapy™ (CTT) A safe, effective in-office treatment for benign prostatic hyperplasia (BPH) that uses microwave energy delivered via a transurethral catheter to heat and reduce excess prostate tissue while circulating cooling fluid to protect the urethra and maintain patient comfort. Performed in a urologist's office in under an hour without general anesthesia, for men suffering lower urinary tract symptoms.
• Prostiva® RF Therapy A safe, effective in-office treatment for BPH that uses low-level radio frequency energy delivered via needles placed directly into the prostate to generate heat and cause coagulation of excess tissue, relieving urethral constriction. Known as Transurethral Needle Ablation (TUNA), the procedure is performed in a urologist's office in under an hour without general anesthesia.

Quantifiable outcome

• Over 90% of Cooled ThermoTherapy patients require no reintervention at 5 years
• +4 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators7 records

Recent moves2 records

Expansion highlights3 records

Broad incumbents

• Olympus Corporation: Olympus is a major urology device manufacturer offering resectoscopes, laser systems, and other BPH surgical solutions; competes with Urologix in the broader BPH treatment category though typically in hospital settings.
• Stryker Corporation: Stryker is a diversified medical device company with surgical and urology portfolios; while not a direct competitor to Urologix's TUMT/TUNA products, it represents a broad incumbent that could expand into office-based BPH therapies.
• KARL STORZ: KARL STORZ produces urological endoscopy and surgical instruments including BPH treatment equipment, representing a broader incumbent competing with Urologix's specialized in-office microwave and RF systems.
• Richard Wolf: Richard Wolf manufactures urology surgical instruments and BPH resection devices, overlapping with Urologix's endourology and minimally invasive urology focus from a hospital-based incumbent angle.

Emerging players

• AngioDynamics: AngioDynamics has explored prostate artery embolization as a minimally invasive BPH treatment, representing an emerging alternative therapy modality that competes with Urologix's in-office thermal approaches.

Direct peers

• PROCEPT BioRobotics: PROCEPT BioRobotics manufactures the Aquablation system for BPH treatment, an emerging robotically-assisted minimally invasive therapy competing with Urologix's in-office BPH offerings.
• Boston Scientific (Rezum): Boston Scientific acquired NxThera and sells the Rezum system, a water vapor thermal therapy for BPH that competes head-to-head with Urologix's TUMT and TUNA platforms in urology offices.
• Teleflex (NeoTract/UroLift): Teleflex acquired NeoTract and markets the UroLift system for in-office BPH treatment, directly competing with Urologix's Cooled ThermoTherapy and Prostiva RF Therapy in the same physician office setting.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/urologixinc
• Facebookfacebook.com/604904482858757
• LinkedInlinkedin.com/company/urologix

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Urologix